These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25258400)

  • 1. SUMOylation: a novel protein quality control modifier in the heart.
    Maejima Y; Sadoshima J
    Circ Res; 2014 Sep; 115(8):686-9. PubMed ID: 25258400
    [No Abstract]   [Full Text] [Related]  

  • 2. Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.
    Gupta MK; Gulick J; Liu R; Wang X; Molkentin JD; Robbins J
    Circ Res; 2014 Sep; 115(8):721-9. PubMed ID: 25097219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
    Ahner A; Gong X; Frizzell RA
    FEBS J; 2013 Sep; 280(18):4430-8. PubMed ID: 23809253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Search and destroy: the role of protein quality control in maintaining cardiac function.
    Patterson C
    J Mol Cell Cardiol; 2006 Apr; 40(4):438-41. PubMed ID: 16516914
    [No Abstract]   [Full Text] [Related]  

  • 5. UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts.
    Gupta MK; McLendon PM; Gulick J; James J; Khalili K; Robbins J
    Circ Res; 2016 Jun; 118(12):1894-905. PubMed ID: 27142163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity.
    Aillet F; Lopitz-Otsoa F; Egaña I; Hjerpe R; Fraser P; Hay RT; Rodriguez MS; Lang V
    PLoS One; 2012; 7(12):e51672. PubMed ID: 23284737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.
    Akinjiyan FA; Carbonneau S; Ross NT
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4589-4596. PubMed ID: 28911816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hip2 interacts with cyclin B1 and promotes its degradation through the ubiquitin proteasome pathway.
    Bae Y; Choi D; Rhim H; Kang S
    FEBS Lett; 2010 Nov; 584(22):4505-10. PubMed ID: 20965177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The regulatory mechanisms of protein expression in heart failure patients' cardiomyocytes. The ubiquitin-proteasome system. Autophagy].
    Pawlak A; Bil J; Gil RJ
    Kardiol Pol; 2012; 70(11):1170-6. PubMed ID: 23180530
    [No Abstract]   [Full Text] [Related]  

  • 10. Sculpting the proteome with small molecules.
    King RW; Finley D
    Nat Chem Biol; 2014 Nov; 10(11):870-4. PubMed ID: 25325686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heart.
    Li F; Zhang L; Craddock J; Bruce-Keller AJ; Dasuri K; Nguyen A; Keller JN
    Mech Ageing Dev; 2008 Sep; 129(9):515-21. PubMed ID: 18533226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small heat shock proteins target mutant cystic fibrosis transmembrane conductance regulator for degradation via a small ubiquitin-like modifier-dependent pathway.
    Ahner A; Gong X; Schmidt BZ; Peters KW; Rabeh WM; Thibodeau PH; Lukacs GL; Frizzell RA
    Mol Biol Cell; 2013 Jan; 24(2):74-84. PubMed ID: 23155000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Discovery to Bedside: Targeting the Ubiquitin System.
    Wertz IE; Wang X
    Cell Chem Biol; 2019 Feb; 26(2):156-177. PubMed ID: 30554913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
    Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ubiquitin ligases in cardiac disease.
    Willis MS; Bevilacqua A; Pulinilkunnil T; Kienesberger P; Tannu M; Patterson C
    J Mol Cell Cardiol; 2014 Jun; 71():43-53. PubMed ID: 24262338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processive ubiquitin chain formation by the anaphase-promoting complex.
    Meyer HJ; Rape M
    Semin Cell Dev Biol; 2011 Aug; 22(6):544-50. PubMed ID: 21477659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBC9 regulates cardiac sodium channel Na
    Tang B; Hu Y; Wang Z; Cheng C; Wang P; Liang L; Xiong H; Luo C; Xu C; Chen Q; Wang QK
    J Mol Cell Cardiol; 2019 Apr; 129():79-91. PubMed ID: 30772377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart.
    Razeghi P; Baskin KK; Sharma S; Young ME; Stepkowski S; Essop MF; Taegtmeyer H
    Biochem Biophys Res Commun; 2006 Apr; 342(2):361-4. PubMed ID: 16483544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome system in cardiomyopathies.
    Schlossarek S; Carrier L
    Curr Opin Cardiol; 2011 May; 26(3):190-5. PubMed ID: 21415726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.